Phase 3 Trial for Melanoma Treatment
Merck & Co. (MRK) and Moderna Inc. (MRNA) have announced the initiation of a Phase 3 trial to evaluate the efficacy of Moderna's V940 in combination with Merck's Keytruda as…
Merck Falls as Updated Efficacy Results of Covid-19 Pill Scores Lower
(Merck) Merck stock fell more than 3% on Friday in premarket after an updated study of its investigational oral antiviral pill, molnupiravir, against COVID-19 showed lower efficacy rates. A MOVe-OUT…
Merck’s Becomes the First to Earn Approval for Covid-19 Pill From the UK
(Reuters) Molnupiravir, a Covid-19 antiviral pill developed by Merck and Ridgeback Biotherapeutics, has been approved by Britain’s regulator, becoming the first in the world. Britain's Medicines and Healthcare products Regulatory…
Merck and Ridgeback Antiviral Drug Outscores Placebo in Covid Treatment Outcomes
(Merck) Merck and Ridgeback Biotherapeutics oral antiviral drug candidate Molnupiravir reduced the risk of Covid-19 hospitalizations or death by about 50% compared to a placebo. An interim Phase 3 study…